India is often referred to as the ‘pharmacy of the world’ and is undeniably the leading manufacturing hub for many of the world’s most essential medicines.
The development of generic versions of innovator medicines is a global public health need.
The issue of addressing potential nitrosamine impurities in medicines has been the focus at events taking place around the globe in recent months and will continue to do so throughout 2023.
How to secure upstream pharmaceutical supply chain risks with data and advanced technologies to increase access to quality medical products for patients
While the global vaccination effort to curb the spread of COVID-19 continues to ramp up worldwide, access to COVID-19 vaccines, particularly in low- and middle-income countries, remains staggeringly low. In fact, low- and middle-income countries received less than one percent of available doses.